Company Profiles

driven by the PitchBook Platform

Opal Therapeutics

Description

Owner and operator of a immunotherapy development company. The company develops therapeutic vaccines for the treatment of HIV and Hepatitis C diseases.

2005

Founded

PRIVATE

Status

Series A

Latest Deal Type

$6M

Latest Deal Amount

$6M

Total Amount Raised

4

Investors

Description

Owner and operator of a immunotherapy development company. The company develops therapeutic vaccines for the treatment of HIV and Hepatitis C diseases.

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Pharmaceuticals and Biotechnology

Other Industries

Drug Discovery

Primary Office

Melbourne, Victoria Australia
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Opal Therapeutics's full profile, request a free trial.

Opal Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Opal Therapeutics Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Alloy VenturesVenture CapitalMinority000 0000000 0000
Alta PartnersVenture CapitalMinority000 0000000 0000
GBS Venture PartnersVenture CapitalMinority000 0000000 0000
UniseedVenture CapitalMinority000 0000000 0000
Alloy Ventures Venture Capital
Alta Partners Venture Capital
GBS Venture Partners Venture Capital
Uniseed Venture Capital

Opal Therapeutics Executive Team (1)

NameTitleBoard
Seat
Contact
Info
Stephen KentFounder
Stephen Kent Founder

Opal Therapeutics Board Members (2)

NameRepresentingRoleSinceContact
Info
Daniel JanneyAlta PartnersManaging Director000 0000
Leighton Read MDAlloy VenturesVenture Partner000 0000
Daniel Janney Managing Director Alta Partners
Leighton Read MD Venture Partner Alloy Ventures
Request full access to PitchBook